|Articles|August 1, 2003

Pharmacy Times

  • Volume 0
  • 0

Statins May Tackle Cancer

Cholesterol-lowering drugs may have a new use?reducing cancer, especially cancer of the kidney and prostate, according to the results of a Dutch study. The study, which looked at drug-dispensing records and hospital discharge records from 8 Dutch cities, found that statin use was connected with a 20% reduction in cancer risk.The researchers compared the use of statin drugs among 3219 patients with cancer and 16, 976 without cancer. All the participants were receiving at least 1 medication for cardiovascular disease.

Lead investigator Matthijs Graaf, PharmD, of the Academic Medical Center at the University of Amsterdam in the Netherlands, said, "People who used statins for less than 4 years did not have a significant risk reduction." The risk of cancer was 36% lower, however, in participants who took statins for at least 4 years, compared with that in people who did not take the drugs. Graaf stressed that more studies are needed before physicians advise patients to take statins solely as a means for decreasing the risk of cancer.

Articles in this issue

about 22 years ago

Competition for the Tooth Fairy

about 22 years ago

Healthy Mouth, Healthy Body

about 22 years ago

Puberty's Role in Breast Cancer

about 22 years ago

Supplements Do Not Enlarge Breasts

about 22 years ago

Seniors Need Extra Dental Care

about 22 years ago

Men Not Up to Par with Women

about 22 years ago

Look to the Taste Buds

about 22 years ago

MRI Shows Course of RA

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME